L'Università degli Studi di Milano-Bicocca è un'università statale italiana fondata nel 1998.

During the past decade, University of Milano Bicocca conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Milano Bicocca" #1 sponsor was "University of Milano Bicocca" with 5 trials, followed by "Ariad Pharmaceuticals" with 1 trials sponsored, "Erasmus Medical Center" with 1 trials sponsored, "Fondazione Don Carlo Gnocchi Onlus" with 1 trials sponsored and "Incyte Biosciences International Sàrl" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Milano Bicocca" #1 collaborator was "Agenzia Italiana del Farmaco" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Milano Bicocca" are "Accelerated Phase Chronic Myeloid Leukemia" (1 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Lymphocytic Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials) and "Blast Phase Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "University of Milano Bicocca" in a lesser frequency.

Most popular intervention types in "University of Milano Bicocca" are "Drug" (3 trials), "Other" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ponatinib" (2 trials), "Hydroxychloroquine + Prednisone" (1 trials), "Prednisone" (1 trials), "Raman analysis of saliva, characterization of the Raman database and building of the classification model" (1 trials) and "Real HD-tDCS + CCT" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Milano Bicocca" are 7 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "University of Milano Bicocca". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Milano Bicocca, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Milano Bicocca, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".